LOH analyses of premalignant and malignant lesions of human breast: frequent LOH in 8p, 16q, and 17q in atypical ductal hyperplasia.

Amari,M; Suzuki,A; Moriya,T; Yoshinaga,K; Amano,G; Sasano,H; Ohuchi,N; Satomi,S; Horii,A

doi:10.3892/or.6.6.1277

LOH analyses of premalignant and malignant lesions of human breast: frequent LOH in 8p, 16q, and 17q in atypical ductal hyperplasia.

Authors:
- M Amari
- A Suzuki
- T Moriya
- K Yoshinaga
- G Amano
- H Sasano
- N Ohuchi
- S Satomi
- A Horii
View Affiliations

Affiliations: Department of Molecular Pathology, Tohoku University School of Medicine, Sendai 980-8575, Japan.
Published online on: November 1, 1999 https://doi.org/10.3892/or.6.6.1277
Pages: 1277-1357

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The number of breast cancer patients is increasing yearly, and it is important to establish effective methods for clinical management. We investigated loss of heterozygosity (LOH) in tumors derived from 23 patients that harbored synchronous lesions of atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS), and invasive ductal carcinoma (IDC). Fourteen selected microsatellite markers that were mapped to and/or very close to the tumor suppressor genes or regions with frequent LOH in breast cancer. Our results suggested that i) losses of chromosomal regions 8p, 16q, and 17q are early genetic changes, and ii) ADH is a premalignant lesion for the development of breast cancer.